Introduction {#afu168_s1}
============

The value of physical activity for the prevention of coronary heart disease, stroke, type 2 diabetes and some cancers is now well established for the adult population \[[@AFU168C1], [@AFU168C2]\]. Further benefits are seen in middle to later life as activity reduces risk of physical disability \[[@AFU168C3]\], and cognitive impairment, dementia and Alzheimer\'s disease \[[@AFU168C4]\]. Evidence is also emerging of the detrimental health effects of sedentary time, independent of physical activity \[[@AFU168C5]\].

Older adults are the least active sector of society. In the United Kingdom, \<30% of 65--74 year olds and 15% of adults aged 75 or over reported any moderate intensity physical activity lasting at least 10 min in the previous 4 weeks \[[@AFU168C6]\]. They are also the most sedentary sector, with US adults aged 60--69 spending over 8 h per day being sedentary \[[@AFU168C7]\]. Given that the older sector of the population is expanding and living longer, the promotion of active lifestyles has potential to extend life and reduce disease and disability.

Surprisingly, few studies have investigated the impact of physical activity on mortality and morbidity among those already in their late 70s and 80s \[[@AFU168C8]--[@AFU168C12]\]. These studies have included adults in their 60s, relied on self-reported physical activity and have yielded equivocal results. In contrast, recent systematic reviews of studies employing objective measures of physical function have shown that lower grip strength, walking speed, leg strength and balance are associated with higher risk of mortality in the over 70s \[[@AFU168C13]\]. A similar review investigating the prospective associations between these aspects of function and health outcomes identified effects for grip strength and walking speed on reduced risk of fracture, but associations with cardiovascular disease and stroke were inconclusive \[[@AFU168C14]\].

Physical activity and aspects of function are also moderately related \[[@AFU168C15]\] and can have reciprocal effects on each other. Low activity contributes to mobility deterioration and higher activity can improve or maintain mobility \[[@AFU168C16]\]. Conversely, mobility limitations, which might arise from conditions such as osteoarthritis or heart conditions can also have a detrimental effect on physical activity \[[@AFU168C17]\]. To separate effects of activity from function, it is therefore important to provide robust assessments of both physical activity and function when investigating mortality and disease outcomes.

Concern has been expressed about the absence of use of objective measures for the assessment of physical activity when investigating mortality and morbidity in older adults \[[@AFU168C18]\]. Self-report is susceptible to socially desirable responding \[[@AFU168C19]\], and older adults have less accurate recall \[[@AFU168C20]\], and their physical activity is mainly walking which is less memorable than activity for leisure or fitness \[[@AFU168C21]\]. Accelerometry provides high precision data which can assess minute-by-minute activity at different levels of intensity, sedentary time and numbers of steps walked. This could be useful in helping identify whether particular levels of intensity are related to health benefit. Similarly, simple, home-based batteries of tests are available that provide valid estimates of several elements of function that reflect tasks of daily living and mobility \[[@AFU168C22]\].

The evidence base for the benefits of physical activity and good physical function remains limited for those already well into older age. This study focused on a population of UK older adults at least 70 years old (mean 78 years). Objective measures of both physical activity and lower limb function were employed to assess their influence on relative risk for all-cause mortality and diagnoses of new diseases over the following 4-year period.

Methods {#afu168_s2}
=======

Project OPAL (Older People and Active Living) was an observational study conducted in 2007/08 with 240 adults aged 70 and older, living in suburban and urban sectors of a large city in south west England. The aim of OPAL was to provide comprehensive objective documentation of physical activity and lower limb function in older people and to identify possible determinants and consequences for health and well-being \[[@AFU168C15], [@AFU168C21], [@AFU168C23], [@AFU168C24]\]. OPAL-PLUS was a follow-up study that provided health data from primary care records over the following 4--5 years \[[@AFU168C25]\]. Ethics approval for both studies was obtained from Bristol Southmead NHS (Ethics reference 06/Q2002/127).

Sample {#afu168_s2a}
------

OPAL participants were recruited from 12 general practitioner (GP) surgeries, stratified by low, medium or high Index of Multiple Deprivation (IMD) and low or high access to local amenities. The sample was selected at random from the list of patients aged 70 or older at each practice following screening by a GP for (i) recent bereavement, (ii) terminal illness, (iii) debilitating mental illness, (iv) inability to complete a questionnaire and (v) any other illness preventing participation. The final OPAL sample consisted of 115 females and 125 males. Age and gender of the sample were similar in distribution to those of the patient lists from which they were drawn. Percentages of either overweight or obese were similar to national distributions for England \[[@AFU168C6]\]. Also, the IMDs of participants\' residence provided a fair representation of the national IMD quartiles \[[@AFU168C26]\] (22.1% \[lowest\]; 27.9, 31.3 and 18.7% \[highest\]).

Baseline measures {#afu168_s2b}
-----------------

OPAL baseline data were collected through two home visits as in Ref. \[[@AFU168C23]\]. For this paper, age (≤75.0--79.9, 80.0--84.9 and ≥85.0 years), gender, highest level of education attained (primary, secondary or tertiary), weight status calculated from measured height and weight (obese---body mass index (BMI) ≥30.0 kg/m^2^; overweight---BMI 25.0--29.9 kg/m^2^; normal/underweight---BMI \<25.0 kg/m^2^), tertiles of IMD of area of residence and number of self-reported diagnosed conditions or diseases were used.

### Physical activity {#afu168_s2b1}

Physical activity was assessed by 7-day accelerometry using Actigraph GT1Ms (<http://www.actigraphcorp.com>) programmed to record in 10-s epochs, to produce both count and pedometer data \[[@AFU168C24]\]. Data were reduced using MAH/UFFE Analyser v. 1.9.0.3 (MRC Epidemiology Unit) set to ignore runs of 100 or more zeros, representing time when the monitor was not worn. Inclusion required at least 10 h of monitoring on at least 5 days. Daily means for registered wear time per day, total minutes of activity at moderate-to-vigorous intensity (MVPA) (\>1,951 CPM), number of steps (STEPS) and minutes of sedentary time (0--99 CPM) were calculated. Additionally, a 7-day journey log recording time, purpose and transport mode of trips from the home was administered \[[@AFU168C21]\] and mean weekly frequency of trips from home (TRIPS) calculated.

### Physical function {#afu168_s2b2}

Participants\' lower limb function was assessed using the Short Physical Performance Battery (SPPB) \[[@AFU168C2]\] that includes home-based tests of leg strength, walking speed and balance. These were summed to produce a lower limb function score.

Follow-up data {#afu168_s2c}
--------------

Data were extracted in October 2012 from the medical records of 213 (104 females) of the original 240 OPAL participants (3 were withdrawn by their GPs, 21 withdrew by choice and 3 were not contactable). Mean lapse time since OPAL baseline assessment was 50 (±14) months. Number of new diagnoses of the chronic illnesses/conditions collected by the Quality Outcomes Framework in primary care (2011--12) \[[@AFU168C27]\] and date and cause of any death were recorded.

Data analyses {#afu168_s2d}
-------------

For ease of interpretation, STEPS representing activity volume, TRIPS indicating mobility from home and sedentary time were grouped into tertiles. MVPA was split into three groups (\<10, 10--29 and ≥30 min). Those in the most active group were therefore reaching recommended amounts, although this included all accumulated minutes rather than those achieved in at least 10-min bouts. Three lower limb function groups were formed (low: ≤6, medium: 7--9, high: 10--12), which differentiate between levels of mobility disability \[[@AFU168C22]\]. ANOVAs were used to assess group differences in these variables in follow-up time, numbers of self-reported disease at baseline and numbers of new diseases recorded during follow-up.

Cox proportional hazard models were computed to address the prospective associations between physical activity and function variables at baseline and subsequent mortality. Poisson regression models, which are better suited for count data, were used to estimate associations with number of newly diagnosed diseases. The incident rate ratios (IRRs) indicate the number of newly diagnosed diseases per year for low and medium groups compared with the high activity or function (reference) group.

For mortality prediction, Model 1 was unadjusted, but for number of newly diagnosed diseases, Model 1 was adjusted for time lapse from baseline to follow-up, or point of death or move to a different practice. Model 2 was adjusted for confounders at baseline known to be associated with mortality and morbidity, including age, gender, educational attainment, IMD, weight status and number of self-reported diseases/conditions. Model 2 was also adjusted for the practice recording system from which the data were extracted, because the four different systems we encountered produced some significant differences in disease diagnoses and health service usage means \[[@AFU168C25]\].

To assess the effects of activity and function independently of each other, for the activity variables, Model 3 was adjusted for lower limb function. For lower limb function, in Model 3, STEPS as an indicator of activity volume was adjusted for mortality, and MVPA as an indicator of higher intensity activity was adjusted for new disease prediction. These activity variables also emerged in Model 2 as the most potent activity variables. All analyses were performed with IBM SPSS 20.0.

Results {#afu168_s3}
=======

All 213 participants whose medical records were examined provided complete physical function, height and weight, and self-reported illnesses data at baseline. Two hundred and eight also provided valid accelerometry data (7 of these did not provide step data due to technical error). There were 33 deaths with a mean time from baseline of 29 (±19) months. There were no statistically significant differences in any socio-demographic variables, pre-existing disease, physical activity or lower limb function between the 213 adults in the final sample and those lost to follow-up (*n* = 27). Zero-order correlations between STEPS, MVPA, TRIPS and lower limb function were *r* = 0.45--0.55, indicating a moderate univariate association.

Mean follow-up times were not significantly different for any of the socio-demographic or weight status groups (Table [1](#AFU168TB1){ref-type="table"}). Significantly more pre-existing diseases were reported at baseline for lower education, higher IMD and BMI groups. In contrast, no significant differences in group means for any socio-demographic variable or BMI groups were seen for numbers of newly diagnosed diseases.Table 1.Follow-up time, baseline disease and new disease by socio-demographics, weight status, physical activity and lower limb function groupsVariablesMean follow-up time(m)Mean (SD) number of self-reported diseases at baselineMean annual number (SD) of new disease diagnoses during follow-upAge (*n* = 213) 70--74.9 (*n* = 78)54 (11)1.33 (1.10)0.26 (0.43) 75--79.9 (*n* = 57)52 (14)1.27 (1.04)0.24 (0.36) 80--84.9 (*n* = 53)50 (16)1.57 (1.27)0.27 (0.29) 85+ (*n* = 25)44 (20)1.60 (1.44)0.36 (0.53)*P* = 0.017*P* = 0.419*P* = 0.645Gender (*n* = 213) Female (*n* = 104)53 (14)1.57 (1.28)0.26 (0.30) Male (*n* = 109)50 (14)1.26 (1.04)0.27 (0.46)*P* = 0.405*P* = 0.054*P* = 0.896Educational attainment (*n* = 213) Primary (*n* = 41)52 (14)1.54 (1.03)^a^0.25 (0.22) Secondary (*n* = 66)49 (16)1.64 (1.29)0.31 (0.37) Tertiary (*n* = 98)53 (12)1.18 (1.12)0.23 (0.42)*P* = 0.286***P* = 0.036***P* = 0.405Index of Multiple Deprivation (*n* = 213) Low (*n* = 68)52 (14)1.00 (0.93)^b^0.26 (0.50) Medium (*n* = 69)49 (16)1.67 (1.23)0.29 (0.34) High (*n* = 76)53 (13)1.54 (1.23)0.25 (0.31)*P* = 0.505***P* = 0.002***P* = 0.824Body mass index (*n* = 213) Normal/underweight (*n* = 73)52 (12)1.12 (1.14)^b^0.23 (0.24) Overweight (*n* = 80)53 (14)1.53 (1.22)0.25 (0.40) Obese (*n* = 60)49 (17)1.60 (1.09)0.33 (0.50)*P* = 0.407***P* = 0.034***P* = 0.294Number of steps per day (*n* = 201) Low (*n* = 64), \<3,19647 (18)^b^1.8 (1.2)^b^0.33 (0.41)^c^ Medium (*n* = 67), 3,196--5,17054 (13)1.2 (1.0)0.27 (0.45) High (*n* = 70), \>5,17055 (8)1.1 (1.1)0.15 (0.17)***P* = 0.003*P* = 0.001*P* = 0.015**Minutes of MVPA per day (*n* = 208) Low (*n* = 76), \<1049 (18)2.0 (1.3)^b^0.32 (0.40)^c^ Medium (*n* = 93), 10--29.9953 (12)1.2 (1.0)0.25 (0.39) High (*n* = 39), 30+52 (10)0.9 (1.1)0.12 (0.16)*P* = 0.072***P* \< 0.001*P* = 0.008**Minutes of sedentary time per day (*n* = 208) Low (*n* = 69), \<63352 (14)1.4 (1.2)0.25 (0.43) Medium (*n* = 70), 633--69652 (14)1.4 (1.0)0.27 (0.35) High (*n* = 69), \>69651 (15)1.4 (1.3)0.24 (0.33)*P* = 0.737*P* = 0.946*P* = 0.921Frequency of trips per week (*n* = 200) Low (*n* = 75), \<850 (17)1.7 (1.3)^b^0.28 (0.35) Medium (*n* = 59), 8--1253 (13)1.3 (1.0)0.31 (0.51) High (*n* = 66), \>1254 (11)1.2 (1.2)0.16 (0.18)*P* = 0.161***P* = 0.049***P* = 0.078Lower limb function score (*n* = 213) Low (27), \<743 (20)^b^1.6 (1.2)0.34 (0.44) Medium (48), 7--948 (18)1.9 (1.3)^d^0.44 (0.62)^d^ High (138), \>954 (11)1.2 (1.0)0.19 (0.22)***P* \< 0.001*P* \< 0.001*P* = 0.009**[^1][^2][^3][^4]

Physical activity, lower limb function and mortality {#afu168_s3a}
----------------------------------------------------

Table [2](#AFU168TB2){ref-type="table"} shows the hazard ratios (HR) for all-cause mortality by level of STEPS, MVPA, TRIPS, sedentary time and lower limb function. A strong and significantly increased risk was seen for low levels of STEPS (HR \[low versus high\] 11.38, 95% CI 2.64--49.04, *P* = 0.001) and MVPA (HR \[low versus high\] 5.56, 95% CI 1.30--23.72, *P* = 0.002) in the unadjusted Model 1. For STEPS only, (HR \[low versus high\] 7.69, 95% CI 1.43--41.20, *P* = 0.054) all-cause mortality remained marginally significant in adjusted Model 2. There was no evidence of an association with mortality for either volume of sedentary time or for trip frequency. However, a strong effect is seen in adjusted Model 2 (HR \[low versus high\] 5.30, 95% CI 1.91--14.72, *P* = 0.006) for lower limb function. Analyses (not shown) were repeated, treating physical activity as continuous variables and revealed similar associations in terms of direction, magnitude and significance. An exception to this was for STEPS which reached statistical significance in Model 3 (additionally adjusted for lower limb function) (HR 0.64 per 1,000 STEPS/day, 95% CI 0.44--0.91, *P* = 0.013).Table 2.Cox proportional regression models predicting all-cause mortality from baseline physical activity and lower limb functionVariablesNumber of deathsPerson yearsModel 1 HR (95% CIs)Model 2 HR (95% CIs)Model 3^a^ HR (95% CIs)Total steps per day (*n* = 201)***P* = 0.001*P* = 0.054***P* = 0.169 Low18252.1811.38 (2.64--49.04)7.69 (1.43--41.20)5.46 (0.91--32.76) Medium8298.204.26 (0.91--20.07)3.99 (0.80--20.01)3.90 (0.77--19.70) High (ref.)2321.141.001.001.00Minutes of MVPA per day (*n* = 208)***P* = 0.002***P* = 0.070*P* = 0.692 Low22308.805.56 (1.30--23.72)3.67 (0.70--19.15)1.84 (0.32--10.75) Medium8414.401.59 (0.34--7.49)1.25 (0.25--6.41)1.19 (0.23--6.24) High (ref.)2171.181.001.001.00Minutes of sedentary time per day (*n* = 208)*P* = 0.317*P* = 0.888*P* \< 1.000 Low7272.050.51 (0.21--1.26)0.81 (0.29--2.24)1.01 (0.35--2.98) Medium10307.800.69 (0.31--1.54)1.04 (0.42--2.55)0.99 (0.39--2.58) High (ref.)15309.911.001.001.00Frequency of trips per week (*n* = 200)*P* = 0.237*P* = 0.808*P* = 0.461 Low18383.501.57 (0.66--3.76)0.98 (0.36--2.65)0.51 (0.17--1.55) Medium5246.190.71 (0.22--2.23)0.71 (0.21--2.37)0.52 (0.14--1.93) High (ref.)7238.771.001.001.00Lower limb function score (*n* = 213)***P* \< 0.001*P* = 0.006***P* = 0.507 Low1198.065.68 (2.50--12.89)5.30 (1.91--14.72)2.05 (0.56--7.51) Medium10191.692.79 (1.21--6.47)2.58 (0.89--7.52)1.69 (0.49--5.83) High (ref.)12623.761.001.001.00[^5][^6][^7]

Physical activity, lower limb function and newly diagnosed disease {#afu168_s3b}
------------------------------------------------------------------

Sixty-two per cent of participants had at least one new disease diagnosed in follow-up. Of 210 newly diagnosed diseases, 60 (30%) were cardiovascular related, 37 (17.4%) arthritis, 35 (16.4%) cancer, 33 (15.5%) kidney disease and 18 (8.5%) some form of mental illness. Low-active and low-function groups had significantly more diseases at baseline. Also, follow-up times differed across STEPS and lower limb function groups and were therefore adjusted in the models predicting new disease. Table [3](#AFU168TB3){ref-type="table"} shows a significantly increased risk for new diseases for low levels of MVPA (IRR 1.67, 95% CI 1.04--2.68, *P* = 0.030) and TRIPS per week (IRR 1.41, 95% CI 0.98--2.05, *P* = 0.045) even after adjustment for all co-variates and lower limb function. No associations were seen for sedentary time or lower limb function. Treating physical activity as continuous variables (not shown) made no difference to this pattern of associations.Table 3.Poisson regression models predicting number of newly diagnosed chronic illnesses from baseline physical activity and lower limb functionVariablesModel 1 IRR (95% CIs)Model 2 IRR (95% CIs)Model 3^a^ IRR (95% CIs)Total steps per day (*n* = 201)*P* = 0.119*P* = 0.074*P* = 0.078 Low1.39 (0.99--1.95)1.32 (0.90--1.95)1.28 (0.83--1.96) Medium1.40 (0.99--1.98)1.48 (1.06--2.08)1.47 (1.05--2.07) High (ref.)1.001.001.00Minutes of MVPA per day (*n* = 208)***P* = 0.017*P* = 0.023*P* = 0.030** Low1.79 (1.17--2.73)1.79 (1.13--2.83)1.67 (1.04--2.68) Medium1.76 (1.16--2.66)1.79 (1.17--2.74)1.78 (1.16--2.72) High (ref.)1.001.001.00Minutes of sedentary time per day (*n* = 208)*P* = 0.647*P* = 0.810*P* = 0.757 Low1.15 (0.85--1.55)1.07 (0.78--1.45)1.09 (0.80--1.49) Medium1.04 (0.75--1.45)0.96 (0.69--1.34)0.97 (0.69--1.36) High (ref.)1.001.001.00Frequency of trips per week (*n* = 200)***P* = 0.019*P* = 0.043*P* = 0.045** Low1.51 (1.09--2.09)1.48 (1.04--2.12)1.41 (0.98--2.05) Medium1.57 (1.11--2.22)1.54 (1.08--2.20)1.57 (1.10--2.26) High (ref.)1.001.001.00Lower limb function score (*n* = 213)*P* = 0.065*P* = 0.171*P* = 0.252 Low1.12 (0.76--1.65)1.15 (0.77--1.71)1.10 (0.71--1.70) Medium1.38 (1.05--1.80)1.36 (0.99--1.86)1.32 (0.95--1.83) High (ref.)1.001.001.00[^8][^9][^10]

Discussion {#afu168_s4}
==========

The benefits of physical activity for the prevention of premature mortality and further morbidity, among people already in their 70s and 80s, are not well established. In this study, steps taken per day were significantly predictive of mortality with the risk being 36% lower for every 1,000 steps taken. This finding supports Brown *et al.* \[[@AFU168C8]\] in a study with women (mean age: 75 years) and men (mean age: 72 years) which found risk reduction for mortality with low volumes of self-reported activity.

Lower limb function also indicated a strong association. Amount of walking is closely related to lower limb function, and both have indicated associations with mortality in previous studies \[[@AFU168C8]--[@AFU168C12], [@AFU168C13]\]. Model 3 of the regression analysis also indicated a degree of co-dependency in the prediction of mortality. There are many reasons why older adults lose lower limb function including osteoarthritis and falls, but physical activity is the most effective way of retaining function. These findings suggest that the maintenance of a moderate volume of walking may therefore be a key factor for reducing risk of premature mortality, even at this later stage of life. Furthermore, there is evidence from the LIFE project in the United States that lower limb function can be maintained or improved in older adults in their 70s and 80s through a regular programme of structured exercise \[[@AFU168C16]\].

Amount of moderate-to-vigorous physical activity was a significant predictor of number of newly diagnosed diseases, even after adjustment for existing disease and lower limb function. This is in line with the evidence base underpinning current physical activity guidelines indicating that the main disease-related benefits are seen with 30 min of MVPA activity each day \[[@AFU168C1], [@AFU168C2]\]. It also corroborates previous results with OPAL participants showing that MVPA is an independent predictor of aspects of health service usage \[[@AFU168C25]\]. In our regressions, the high MVPA reference group included those who achieved 30 min per day (50.1 ± 25.4), compared with low and medium groups with mean MVPA of 3.7 and 18.1 min, respectively. However, only three individuals reached the high MVPA group volume through bouts lasting at least 10 min that features in guidelines. This is reflected in findings from a recent national survey in the United Kingdom, also based on accelerometry \[[@AFU168C28]\], showing only 7% of men and 3% of women met recommended amounts through 10-min bouts. Our results suggest that for adults of this age, the recommended amount of MVPA is beneficial even if it is accumulated in short bouts. Our previous analyses of the OPAL cohort data indicated that the bulk of total activity and MVPA was accumulated through active daily journeys for shopping and visiting friends \[[@AFU168C21]\]. 'Walk and rest for a minute' may be a useful strategy for adults in this age group, particularly those working towards the recommended targets.

A surprising finding is that the frequency of trips from home also emerged as an independent predictor of newly diagnosed disease. The association of frequency of trips with MVPA was moderate (*r* = 0.44), a finding recently supported by national-level accelerometry data \[[@AFU168C28]\]. However, our measure included all trips from the home regardless of the mode of transport, so that car and bus journeys were included. The higher tertile (reference group) included 12 (mean = 15.95) or more trips per week, and it is likely to be made up of people with socially involved lives which itself is related to reduced risk of mortality \[[@AFU168C29]\].

Although OPAL participants spent on average 11 h per day sedentary, our data showed no associations for sedentary time. Volume of sedentary time showed limited variance, with a standard deviation of \<10% within each level, and this may have influenced its predictive power. Furthermore, the identification of sedentary time by use of accelerometer counts of 0--99 per minute has been challenged and may lack validity \[[@AFU168C30]\].

Limitations {#afu168_s5}
===========

The sample size of 213 was small compared with most prospective cohort studies. Although the strength of OPAL-PLUS was the objective assessment of physical activity and function, accelerometry requires cut points in movement counts to define MVPA and sedentary time. For older adults, these are based on very limited data and may be prone to misclassification.

Mortality and disease have some co-dependence, and this may have influenced our results. Those who died early have had less time to contract new disease, whereas those who are already at risk of premature mortality may contract new conditions at a more rapid rate. Our analyses indicated that significantly more new diseases were recorded for those who died than survivors, even within a shorter follow-up. However, our regression results were unaffected, possibly because there were only 33 deaths.

A particular challenge with prospective cohort studies is the possibility of unmeasured, or poorly measured, factors being the true explanation of associations. Although we adjusted regressions for most established confounders, we did not include smoking or alcohol consumption. Also, there is a possibility that unidentified subclinical disease at baseline was associated with lower activity levels, and this may contribute to some associations.

Conclusions {#afu168_s6}
===========

Even in this relatively small sample, the benefits of physical activity for reduced risk of premature mortality and further development of disease in older adults in their 70s and 80s can be seen. Volume of activity and amount of MVPA both emerge as important, with the effect for MVPA seen independently of lower limb function and even if it is accumulated in bouts shorter than 10 min. These findings indicate that physical activity should be encouraged in adults throughout their 70s and 80s, regardless of level of lower limb function and existing disease.Key points• The health benefits of physical activity for adults in their 70s and 80s are not established.• Objective measures of activity and function have not been used in prospective studies with this age group.• Volume of activity (as measured by steps per day) and function are predictive of reduced risk of mortality.• Moderate-to-vigorous activity is predictive of reduced risk of new disease diagnosis, independent of lower limb function.• Physical activity is beneficial for this age group regardless of socio-demographic characteristics, function and disease status.
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[^1]: ^a^Low and medium significantly different to high group.

[^2]: ^b^Low significantly different to medium and high group.

[^3]: ^c^Low significantly different to high group.

[^4]: ^d^Medium significantly different to high group.

[^5]: HR, hazards ratio with confidence intervals (CIs).

[^6]: Model 1: unadjusted; Model 2: adjusting for age, gender, educational attainment, IMD, weight status, GP Management System and number of self-reported chronic illnesses at baseline; Model 3: additionally adjusting for lower limb function.

[^7]: ^a^In Model 3 for lower limb function additionally adjusting for STEPS.

[^8]: IRR, incident rate ratio with confidence intervals (CIs).

[^9]: Model 1: adjusting for time to follow-up; Model 2: adjusting for time to follow-up, age, gender, educational attainment, IMD, weight status, GP Management System and number of self-reported chronic illnesses at baseline; Model 3: additionally adjusting for lower limb function.

[^10]: ^a^In Model 3 for lower limb function additionally adjusting for MVPA.
